Swiss National Bank’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-28,300
Closed -$1.1M 2602
2017
Q3
$1.1M Hold
28,300
﹤0.01% 2001
2017
Q2
$846K Sell
28,300
-2,100
-7% -$54.4K ﹤0.01% 2154
2017
Q1
$807K Sell
30,400
-2,100
-6% -$52K ﹤0.01% 2154
2016
Q4
$722K Buy
32,500
+9,700
+43% +$181K ﹤0.01% 2228
2016
Q3
$422K Hold
22,800
﹤0.01% 2406
2016
Q2
$371K Buy
22,800
+7,600
+50% +$128K ﹤0.01% 2477
2016
Q1
$210K Buy
15,200
+9,500
+167% +$128K ﹤0.01% 2550
2015
Q4
$97K Buy
+5,700
New +$111K ﹤0.01% 2638

Other funds holding NDRM

Swiss National Bank's NDRM Position: Q4 2017 in Review

Swiss National Bank sold out of NeuroDerm Ltd. Ordinary Shares (NDRM) in Q4 2017, closing a stake of 28,300 shares — an estimated $1.1M sold.

Swiss National Bank first reported a position in NDRM in Q4 2015 and held it in 8 quarters. The position peaked at $1.1M in Q3 2017. 5 funds tracked by Wall St. Rank hold NDRM as of Q4 2017.

  • Swiss National Bank reported no remaining NeuroDerm Ltd. Ordinary Shares position as of Q4 2017 after selling out during the quarter.
  • Swiss National Bank sold 28,300 NeuroDerm Ltd. Ordinary Shares shares in Q4 2017, an estimated $1.1M.
  • Swiss National Bank first reported a position in NeuroDerm Ltd. Ordinary Shares in Q4 2015 and held it in 8 quarters.
  • Swiss National Bank's NeuroDerm Ltd. Ordinary Shares position peaked at $1.1M in Q3 2017.
  • 5 funds tracked by Wall St. Rank held NeuroDerm Ltd. Ordinary Shares as of Q4 2017.

Based on Swiss National Bank's 13F filing for Q4 2017, filed 7 Feb 2018.